These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 1279689)
1. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Bacharach E; Itin A; Keshet E Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10686-90. PubMed ID: 1279689 [TBL] [Abstract][Full Text] [Related]
2. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes. Liu YX; Hu ZY; Liu K; Byrne S; Zou RJ; Ny T; d'Lacey C; Ockleford CD Placenta; 1998; 19(2-3):171-80. PubMed ID: 9548184 [TBL] [Abstract][Full Text] [Related]
3. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression. Liu K; Liu YX; Hu ZY; Zou RY; Chen YJ; Mu XM; Ny T Mol Cell Endocrinol; 1997 Oct; 133(2):109-16. PubMed ID: 9406856 [TBL] [Abstract][Full Text] [Related]
4. Presence of urokinase plasminogen activator and plasminogen activator inhibitor-1 messenger ribonucleic acids in rat endometrium during decidualization in vivo. Wang S; Kennedy TG; Zhang X Biol Reprod; 1996 Sep; 55(3):493-7. PubMed ID: 8862764 [TBL] [Abstract][Full Text] [Related]
5. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development. Li M; Karakji EG; Xing R; Fryer JN; Carnegie JA; Rabbani SA; Tsang BK Endocrinology; 1997 Jul; 138(7):2790-9. PubMed ID: 9202219 [TBL] [Abstract][Full Text] [Related]
7. Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. Bajou K; Lewalle JM; Martinez CR; Soria C; Lu H; Noël A; Foidart JM Int J Cancer; 2002 Aug; 100(5):501-6. PubMed ID: 12124797 [TBL] [Abstract][Full Text] [Related]
8. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation. Hägglund AC; Ny A; Liu K; Ny T Endocrinology; 1996 Dec; 137(12):5671-7. PubMed ID: 8940398 [TBL] [Abstract][Full Text] [Related]
9. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781 [TBL] [Abstract][Full Text] [Related]
10. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development. Teesalu T; Blasi F; Talarico D Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098 [TBL] [Abstract][Full Text] [Related]
11. Expression and regulation of plasminogen activators, plasminogen activator inhibitor type-1, and steroidogenic acute regulatory protein in the rhesus monkey corpus luteum. Liu K; Feng Q; Gao HJ; Hu ZY; Zou RJ; Li YC; Liu YX Endocrinology; 2003 Aug; 144(8):3611-7. PubMed ID: 12865343 [TBL] [Abstract][Full Text] [Related]
12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
13. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2. Liu JW; Wei DZ; Du CB; Zhong JJ Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716 [TBL] [Abstract][Full Text] [Related]
15. Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes. Teesalu T; Blasi F; Talarico D Mech Dev; 1996 May; 56(1-2):103-16. PubMed ID: 8798151 [TBL] [Abstract][Full Text] [Related]
16. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572 [TBL] [Abstract][Full Text] [Related]
17. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653 [TBL] [Abstract][Full Text] [Related]
18. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. Shweiki D; Itin A; Neufeld G; Gitay-Goren H; Keshet E J Clin Invest; 1993 May; 91(5):2235-43. PubMed ID: 7683699 [TBL] [Abstract][Full Text] [Related]